Carrie L. Cardenas

Internal Medicine
3330 3rd Ave Ste 402
San Diego, CA 92103

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1 publications

Once-daily oral omadacycline versus twice-daily oral linezolid for acute bacterial skin and skin structure infections (OASIS-2): a phase 3, double-blind, multicentre, randomised, controlled, non-inferiority trial.

Once-daily oral omadacycline versus twice-daily oral linezolid for acute bacterial skin and skin structure infections (OASIS-2): a phase 3, double-blind, multicentre, randomised, controlled, non-inferiority trial.

Journal: The Lancet. Infectious diseases
Published: December 11, 2018
Showing 1-1 of 1

Last Updated: 09/26/2026